1 / 5

Global Neurological Disorder Drugs Market Growth, Size, Share, Industry Report and Forecast to 2026

The global neurological disorder drugs market is projected to grow at a significant CAGR during the forecast period (2020-2026). The key factors that drive the growth of the market include the rising prevalence of neurological disorders across the globe, which in turn, creates demand for proper treatment and hence drives the market growth.

larebomrglobal
Télécharger la présentation

Global Neurological Disorder Drugs Market Growth, Size, Share, Industry Report and Forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Neurological Disorder Drugs Market Share, Trends, Size, Research and Forecast 2020-2026 Request a free sample of our report on Neurological Disorder Drugs Market@ https://www.omrglobal.com/request-sample/neurological-disorder-drugs-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780304040

  2. The global neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). The key factors that drive the growth of the market include the rising prevalence of neurological disorders, rising geriatric population, rapid R&D activities by the players in the field along with the technological advancement by the key players operating in the global neurological disorder drugs market. Besides, the presence of the key players also supports the growth of the neurological disorder drugs industry. Players such as Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Allergan Plc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, and Teva Pharmaceutical Industries Ltd. among others. A full Report of Global Neurological https://www.omrglobal.com/industry-reports/neurological-disorder-drugs-market These players are continuously contributing to the growth of the market by adopting several growth strategies in order to curb a large customer base as well as thrive in such a competitive market. For instance, in May 2019, Allergan Plc announced to share approximately 29 presentations at the 71st Annual American Academy of Neurology (AAN) Meeting regarding neurological disorders and their treatment options. Further, in December 2019, Ubrelvy was approved by the US FDA. Ubrelvy is a novel drug manufactured by Allergan Plc for the treatment of neurological disorders especially migraine. With the introduction of a novel drug, the company aims to strengthen its product portfolio. Hence, such aforementioned factors are likely to positively influence market growth. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/neurological-disorder-drugs-market Market Coverage •Market number available for – 2019-2026 •Base year- 2019 •Forecast period- 2020-2026 •Segment Covered- By Disorder Type •Regions Covered- North America, Europe, Asia-Pacific, Rest of the World •Competitive Landscape- Merck & Co. Inc., Novartis International AG, Boehringer Ingelheim International GmbH, Pfizer inc., Teva Pharmaceutical Industries Ltd., Allergan Plc., AstraZeneca Plc, and Eisai Co., Ltd. Disorder Drugs Market Available at

  3. Key questions addressed by the report •What is the market growth rate? •Which segment/region dominates the market in the base year? •Which segment/region will project the fastest growth in the market? •How COVID-19 impacted the market? •Who is the leader in the market? •How players are addressing challenges to sustain growth? •Where is the investment opportunity? Global Neurological Disorder Drugs Market – Segmentation By Disorder Type •Alzheimer’s Disease •Parkinson’s Disease •Multiple Sclerosis •Huntington Disease •Others Global Neurological Disorder Drugs Market – Segmentation by Region North America •United States •Canada Europe •UK •Germany •Italy •Spain •France Rest of Europe Asia-Pacific •China •India

  4. •Japan •Rest of Asia-Pacific Rest of the World •Latin America •Middle East & Africa Company Profiles •AbbVie Inc. •AB Science •ACADIA Pharmaceuticals Inc. •ApotexInc. •Axovant Gene Therapies Ltd. •Allergan Plc •AstraZeneca Plc •Bausch Health Companies Inc. •BayerAG •Biogen Inc. •Boehringer Ingelheim International GmbH •Cipla Ltd. •Daiichi Sankyo Espha Co., Ltd. •Eisai Co. Ltd. •Eli Lilly and Co. •F. Hoffmann-La Roche Ltd. •GlaxoSmithKline Plc •Merck & Co. Inc. •Novartis International AG •Otsuka Pharmaceutical Co., Ltd. •Pfizer Inc. •Sanofi SA •Sun Pharmaceutical Industries Ltd. •Teva Pharmaceutical Industries Ltd. •Vertical Pharmaceuticals, LLC •Wockhardt Ltd. For More Customized Data, Request for Report Customization https://www.omrglobal.com/report- customization/neurological-disorder-drugs-market

  5. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related